20 18 Donor Report
Total Page:16
File Type:pdf, Size:1020Kb
20 DONOR 18REPORT Join us in the fight at fecri.org.au Vision To help us move closer to a cure, About us Fiona’s legacy The Institute has published Through world-class research, to bring hope to those touched by cancer. 50+ The inspiration for a regional to go through what she was going publications to date. Each day 396 Australians will be diagnosed with Victorian cancer research through - insightful and brave from a Mission young girl battling a terminal disease. cancer. Families and friends facility came from a young are shattered by the way a cancer patient, Fiona Elsey, Speaking about the death of a To advance the understanding and treatment of young child is particularly difficult. challenging illness affects who planted a seed in the cancer by making an internationally recognised mind of her oncologist, her It represents every parents’ worst their loved ones and each nightmare and every doctors’ most contribution to cancer research. family and her community. 14 day people continue to die. challenging situation. But in 1991, From Fiona’s dream, a garden community fundraisers held in 2018 Diagnosis and treatments are the statistics around Fiona’s illness of hope has grown in the improving all the time. But meant that the likelihood of surviving form of a world-renowned this illness was remote. What a while this disease kills, we research institute in Ballarat. doctor needs to do is continue trying Thank you for your support must continue our part in to outwit the disease, remaining researching for a cure. Fiona grew up in Ballarat in regional hopeful, but also being practical. Victoria and attended Ballarat High Fiona needed care, particularly during Because of the generosity of our donor community, School. In 1990 she was diagnosed 6 The Fiona Elsey Cancer Research Institute the final stages of her illness and with Ewing’s sarcoma at the age of we have been able to develop an internationally is making a world class contribution to George Kannourakis provided that next generation scientists 13. She underwent treatment at the recognised research program in Ballarat cancer research, with recent recognition care. Royal Children’s Hospital, where she participated in our work for achievements into immunotherapy was treated by Ballarat paediatric Fiona lost her fight for life in 1991, experience program held in 2018 targets for ovarian cancer and histiocytic As a non- government funded organisation, the oncologist and haematologist Dr aged 14, but she inspired all those disorders. Institute relies on the community’s support to George Kannourakis. Ewings Sarcoma around her, including her local community. The community rallied to maintain and build the research program. This is Our research team are working hard to at this time had a survival rate of 5% Tissue bank of over unlock the riddles of cancer. We are well and despite treatment Fiona’s disease raise the initial funds to support the done through wonderful donations of money and positioned to do this, with world class progressed. establishment of what was known as time. facilities at the Ballarat Technology Park, the Ballarat Cancer Research Centre. The relationship between doctor and and a tissue bank of over 3000 patient In 1998, the Fiona Elsey Cancer patient is particularly intimate and samples, that is facilitated through Research Laboratory, named in Fiona’s 3,000 especially when the patient is dying. the support of medical clinicians that memory, was officially opened. George Kannourakis was pivotal in patient samples recognise its importance. Additionally, our Advancing the understanding and treatment of enabling Fiona to remain at home team maintains an extensive program of cancer by making an internationally recognised in her final weeks. During this time, local and international collaborations with Fiona asked George why cancer contribution to cancer research other research centres. research only occurred in capital cities. She made him promise that he would 189 to make her dream of a regional research centre a reality and work volunteers helped in 2018 so that other people would not have Over “This was her dream, to see research 10,000 happen in her home town.” Gail Elsey registered supporters 1 FIGHTING CANCER THROUGH RESEARCH 1 Contents Message from Our Chair Message From Our Chair 3 our donors and volunteers with the recognised by awarding him Governor confidence that their gifting is managed of the Institute. I thank my fellow responsibly and put to best use. members of the Board, who freely donate 2018 at a Glance 4 their time and expertise to guide the We are a lean but agile organisation Institute. My gratitude is extended to with a clear focus on our mission. The our Honorary Institute Director Professor Institute’s brand is associated with George Kannourakis who generously Message From Our Honorary Director 6 excellence in research and professionalism gives his time and energy, overseeing of researchers and students. Our the day-to day activities of the Institute, reputation continues to strengthen with whilst running a very busy professional Our Research 8 the publication of several significant oncology and haematology practice. research papers and presentations at national and international symposiums On behalf of the Board I am Senior Research Staff 13 in 2018. We enjoy unique collaborative delighted to present our 2018 relationships with highly respected Donor Report. national and internationally significant research organisations and a strong As I write this report, we enter our twenty Our team continues to Collaborative Partnerships And Networks 14 partnership with Federation University. first anniversary of the establishment deliver at the highest of the Institute. It is a time to reflect The Institute Director has articulated level in all that they do Research Team 10 with pride on how we have grown and his aspirational view of the Institute developed a boutique cancer research with the Board and I am excited to see organisation located in regional Ballarat what the future brings as we continue into a nationally and internationally to shape our future with your support. Lastly, I want to express my sincere Publications 16 recognised cancer research identity. Research takes time and money, and as gratitude to our donors, supporters and a non-government funded organisation Cancer is a national health priority and volunteers, who each year contribute so we are dependent on the generosity of our primary objective is to identify much to our cause. Your contribution be it the community to provide the necessary Board of Directors 17 causes of cancer via breakthrough financial dollars or your time, is crucial to funding to continue our work. Into the discoveries and translate these into new our existence and is highly valued. future we will need to grow our funding ways to diagnose, treat and prevent base to ensure a consistent influx of cancer. Our research continues to focus Financial Commentary 18 funds to advance our research. We need on immunotherapy initiatives to deliver to identify new sources of funding, recruit better outcomes for people affected a new generation of donors and apply by cancer. Our progress over the last Donor Contribution 20 novel ways to build our presence beyond twelve months has been remarkable, our traditional funding base. This work is our collaborations with research essential to ensure that the organisation teams nationally and internationally can manage growth and innovation into Fundraisers And Events 24 continue to increase and our standing the future. in the international research community Graeme Dixon continues to grow I would like to take this opportunity to express my gratitude to former Board B Bus, FCPA, FCIS, FGIA The Institute’s success is all about its Chair, Board of Management Chairman, Emeritus Prof Wayne Robinson people; our team continues to deliver for helping to make the Institute the at the highest level in all that they do, well governed, accountable and vital backed by our engaged and passionate organisation it is today. It was a pleasure Board. The Institute’s Board of Directors to have worked with him on the board oversees the proper governance and during his 14-year tenure. His service was sustainability of the Institute, providing FIGHTING CANCER THROUGH RESEARCH 3 2018 at a glance July August George Kannourakis published drug delivery systems for the new research findings into treatment of aggressive ovarian the immune response of cancer.’, in the journal, Applied Chemoresistant Ovarian Cancer Materials & Interfaces- July Stem Cells. This was published 2018 Jan Feb in journal, Seminars in Cancer Biology. Visiting Post Doctorial 1900 participants raised over International Journal Molecular Researcher and Clinician, $185,000 at the 2018 Ballarat Science. Graeme Dixon appointed the A collaboration including, Dr Prashanth Prithviraj in New Institute website was Cycle Classic. In collaboration with a team from new Chair of the Board on the Institute researchers Professor collaboration, published launched www.fecri.org.au retirement of Emeritus Professor Nuzhat Ahmed and Ruth results in ‘Monitoring Immune Ruth Escalona- PhD Candidate, the University of Melbourne, Special screening event of Wayne Robinson. Escalona- PhD Candidate Checkpoint Regulators as Professor Nuzhat Ahmed, and Professor Stuart Berzins Mama Mia 2- The Movie held in Professor George Kannourakis published results, ‘Human blood published a paper ‘Paclitaxel- Predictive Biomarkers in Professor Nuzhat Ahmed, Ruth Horsham raising $2,800.00 for published a review of ‘The MAIT cell subsets defined using loaded self-assembled lipid Hepatocellular Carcinoma.’, the Escalona- PhD Candidate, Dr. the Institute. many facets of metzincins and MR1 tetramers’ in the journal of nanoparticles as targeted Frontier Oncology. Dilys Leung, and Professor their endogenous inhibitors: Immunology and Cell Biology. The Institute was charity partner The Institute promoted Ovarian perspectives on ovarian cancer of the 2018 FedUni Road Cancer Awareness month to progression, chemoresistance National Cycling Championships shine a light on our research.